Highly purified mussel adhesive protein to secure biosafety for in vivo applications

Abstract

BackgroundUnique adhesive and biocompatibility properties of mussel adhesive proteins (MAPs) are known for their great potential in many tissue engineering and biomedical applications. Previously, it was successfully demonstrated that redesigned hybrid type MAP, fp-151, mass-produced in Gram-negative bacterium Escherichia coli, could be utilized as a promising adhesive biomaterial. However, purification of recombinant fp-151 has been unsatisfactory due to its adhesive nature and polarity which make separation of contaminants (especially, lipopolysaccharide, a toxic Gram-negative cell membrane component) very difficult.ResultsIn the present work, we devised a high resolution purification approach to secure safety standards of recombinant fp-151 for the successful use in in vivo applications. Undesirable impurities were remarkably eliminated as going through sequential steps including treatment with multivalent ion and chelating agent for cell membrane washing, mechanical cell disruption, non-ionic surfactant treatment for isolated inclusion body washing, acid extraction of washed inclusion body, and ion exchange chromatography purification of acid extracted sample. Through various analyses, such as high performance liquid chromatographic purity assay, limulus amoebocyte lysate endotoxin assay, and in vitro mouse macrophage cell tests on inflammation, viability, cytotoxicity, and apoptosis, we confirmed the biological safety of bacterial-derived purified recombinant fp-151.ConclusionsThrough this purification design, recombinant fp-151 achieved 99.90% protein purity and 99.91% endotoxin reduction that nearly no inflammation response was observed in in vitro experiments. Thus, the highly purified recombinant MAP would be successfully used as a safety-secured in vivo bioadhesive for tissue engineering and biomedical applications.

Mussel adhesion-employed water-immiscible fluid bioadhesive for urinary fistula sealing

“…Overall, WIMBA could be a promising alternative for effective urinary fistula management due to its multiple outstanding physical properties. For more practical use, further studies on the in vivo urinary fistula sealing of WIMBA having proven biological safety [45] will be performed with reduction of curing time and oxidant concentration by employing several strategies (e.g., direct mixing of oxidant). In addition, this novel underwater tissue adhesive sealant also shows significant potential for use in many other internal Fig.…”

Rapidly light-activated surgical protein glue inspired by mussel adhesion and insect structural crosslinking

“…Previously, to overcome limited applications due to the extreme difficulty in preparing natural MAPs, hybrid-type recombinant MAP was newly designed and successfully mass-produced in bacterial system [8,9]. This recombinant MAP has proven to be flexible, biodegradable, biocompatible, and strongly adhesive on various surfaces [9,11]. However, due to the intrinsic inabilities of a bacterial system such as lack of post-translational modifications, enzyme-mediated DOPA modification step is required to prepare DOPA-containing recombinant MAP.…”

Adding Functions to Biomaterial Surfaces through Protein Incorporation

“…studied to date but the increasing ability to produce the proteins recombinantly [224] and to purify them to near-homogeneity [225] will see greater investigation of these and similar proteins as broadly effective bioactive coatings of inert materials in coming years. Collagen adhesion protein has also been used to increase the interfacial strength between a poly(vinyl alcohol) implant and articular cartilage, though this increased integration was significantly reduced in vitro after only 21 days.…”